89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 170 filers reported holding 89BIO INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,260,201 | -70.3% | 599,754 | -63.6% | 0.00% | -66.7% |
Q2 2023 | $31,210,954 | +27.1% | 1,647,016 | +2.1% | 0.00% | 0.0% |
Q1 2023 | $24,563,538 | +1735.8% | 1,612,839 | +1434.4% | 0.00% | – |
Q4 2022 | $1,338,063 | +74.5% | 105,111 | -20.6% | 0.00% | – |
Q3 2022 | $767,000 | +142.0% | 132,365 | +34.6% | 0.00% | – |
Q2 2022 | $317,000 | +20.1% | 98,359 | +39.9% | 0.00% | – |
Q1 2022 | $264,000 | -48.1% | 70,309 | +80.5% | 0.00% | – |
Q4 2021 | $509,000 | -87.9% | 38,956 | -81.8% | 0.00% | -100.0% |
Q3 2021 | $4,200,000 | -2.7% | 214,384 | -7.1% | 0.00% | 0.0% |
Q2 2021 | $4,317,000 | -46.1% | 230,879 | -31.7% | 0.00% | 0.0% |
Q1 2021 | $8,003,000 | -24.8% | 337,970 | -22.7% | 0.00% | -50.0% |
Q4 2020 | $10,649,000 | +17075.8% | 436,969 | +18061.6% | 0.00% | – |
Q3 2020 | $62,000 | -92.3% | 2,406 | -94.1% | 0.00% | – |
Q2 2020 | $809,000 | +274.5% | 40,624 | +374.9% | 0.00% | – |
Q1 2020 | $216,000 | -70.2% | 8,554 | -68.9% | 0.00% | – |
Q4 2019 | $724,000 | – | 27,542 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 11,416,948 | $216,351,165 | 4.08% |
Orchard Capital Management, LLC | 542,879 | $10,287,557 | 3.46% |
Artia Global Partners LP | 465,465 | $8,820,562 | 3.04% |
Octagon Capital Advisors LP | 1,066,784 | $20,215,557 | 2.81% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,393,236 | $45,351,822 | 2.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 396,497 | $7,513,618 | 2.32% |
Boxer Capital, LLC | 2,100,000 | $39,795 | 1.85% |
Velan Capital Investment Management LP | 95,000 | $1,800,250 | 1.67% |
Cormorant Asset Management, LP | 1,350,000 | $25,582,500 | 1.43% |
Tri Locum Partners LP | 165,897 | $3,143,748 | 1.17% |